These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 11800503

  • 21. Comparative efficacy of SSRIs and amisulpride in burning mouth syndrome: a single-blind study.
    Maina G, Vitalucci A, Gandolfo S, Bogetto F.
    J Clin Psychiatry; 2002 Jan; 63(1):38-43. PubMed ID: 11838624
    [Abstract] [Full Text] [Related]

  • 22. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A, Wetzel H, Angersbach D, Dunbar GC, Schwarze H, Philipp M, Benkert O.
    Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
    [Abstract] [Full Text] [Related]

  • 23. A double-blind, randomized comparative trial of amisulpride versus olanzapine for 6 months in the treatment of schizophrenia.
    Mortimer A, Martin S, Lôo H, Peuskens J, SOLIANOL Sudy Group.
    Int Clin Psychopharmacol; 2004 Mar; 19(2):63-9. PubMed ID: 15076013
    [Abstract] [Full Text] [Related]

  • 24. Restoring Study 329: efficacy and harms of paroxetine and imipramine in treatment of major depression in adolescence.
    Le Noury J, Nardo JM, Healy D, Jureidini J, Raven M, Tufanaru C, Abi-Jaoude E.
    BMJ; 2015 Sep 16; 351():h4320. PubMed ID: 26376805
    [Abstract] [Full Text] [Related]

  • 25. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
    Carpenter DJ, Fong R, Kraus JE, Davies JT, Moore C, Thase ME.
    J Clin Psychiatry; 2011 Nov 16; 72(11):1503-14. PubMed ID: 21367354
    [Abstract] [Full Text] [Related]

  • 26. Comparison of Hypericum extract WS 5570 and paroxetine in ongoing treatment after recovery from an episode of moderate to severe depression: results from a randomized multicenter study.
    Anghelescu IG, Kohnen R, Szegedi A, Klement S, Kieser M.
    Pharmacopsychiatry; 2006 Nov 16; 39(6):213-9. PubMed ID: 17124643
    [Abstract] [Full Text] [Related]

  • 27. Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial.
    Rüther E, Degner D, Munzel U, Brunner E, Lenhard G, Biehl J, Vögtle-Junkert U.
    Pharmacopsychiatry; 1999 Jul 16; 32(4):127-35. PubMed ID: 10505482
    [Abstract] [Full Text] [Related]

  • 28. A double-blind, randomised, controlled clinical trial of acetyl-L-carnitine vs. amisulpride in the treatment of dysthymia.
    Zanardi R, Smeraldi E.
    Eur Neuropsychopharmacol; 2006 May 16; 16(4):281-7. PubMed ID: 16316746
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials.
    Dunner DL, Lipschitz A, Pitts CD, Davies JT.
    Clin Ther; 2005 Dec 16; 27(12):1901-11. PubMed ID: 16507376
    [Abstract] [Full Text] [Related]

  • 30. Amisulpride versus flupentixol in schizophrenia with predominantly positive symptomatology -- a double-blind controlled study comparing a selective D2-like antagonist to a mixed D1-/D2-like antagonist. The Amisulpride Study Group.
    Wetzel H, Gründer G, Hillert A, Philipp M, Gattaz WF, Sauer H, Adler G, Schröder J, Rein W, Benkert O.
    Psychopharmacology (Berl); 1998 Jun 16; 137(3):223-32. PubMed ID: 9682999
    [Abstract] [Full Text] [Related]

  • 31. Mirtazapine compared with paroxetine in major depression.
    Benkert O, Szegedi A, Kohnen R.
    J Clin Psychiatry; 2000 Sep 16; 61(9):656-63. PubMed ID: 11030486
    [Abstract] [Full Text] [Related]

  • 32. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP, Spina E, Murray S, Yang R.
    Int Clin Psychopharmacol; 2006 May 16; 21(3):143-51. PubMed ID: 16528136
    [Abstract] [Full Text] [Related]

  • 33. Mirtazapine versus venlafaxine in hospitalized severely depressed patients with melancholic features.
    Guelfi JD, Ansseau M, Timmerman L, Kørsgaard S, Mirtazapine-Venlafaxine Study Group.
    J Clin Psychopharmacol; 2001 Aug 16; 21(4):425-31. PubMed ID: 11476127
    [Abstract] [Full Text] [Related]

  • 34. A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.
    Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.
    Curr Med Res Opin; 2006 Jul 16; 22(7):1331-41. PubMed ID: 16834832
    [Abstract] [Full Text] [Related]

  • 35. Amisulpride compared with standard neuroleptics in acute exacerbations of schizophrenia: three efficacy studies.
    Freeman HL.
    Int Clin Psychopharmacol; 1997 May 16; 12 Suppl 2():S11-7. PubMed ID: 9218163
    [Abstract] [Full Text] [Related]

  • 36. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
    Fang Y, Yuan C, Xu Y, Chen J, Wu Z, Cao L, Yi Z, Hong W, Wang Y, Jiang K, Gao K, Cui X, Nierenberg AA, OPERATION Study Team.
    J Clin Psychopharmacol; 2010 Aug 16; 30(4):357-64. PubMed ID: 20571433
    [Abstract] [Full Text] [Related]

  • 37. A double-blind, comparative, multicentre study comparing paroxetine with fluoxetine in depressed patients.
    De Wilde J, Spiers R, Mertens C, Bartholomé F, Schotte G, Leyman S.
    Acta Psychiatr Scand; 1993 Feb 16; 87(2):141-5. PubMed ID: 8447241
    [Abstract] [Full Text] [Related]

  • 38. A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.
    Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH.
    J Clin Psychiatry; 1997 Mar 16; 58(3):112-8. PubMed ID: 9108813
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.